ZOON.F Stock Overview
Engages in the research, development, and sale of a range of antimicrobial products in New Zealand, Australasia, Asia, the United States, India, the United Kingdom, and Europe. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Zoono Group Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$0.01 |
52 Week High | AU$0.07 |
52 Week Low | AU$0.003 |
Beta | 0.31 |
11 Month Change | -33.33% |
3 Month Change | n/a |
1 Year Change | -60.00% |
33 Year Change | -80.00% |
5 Year Change | n/a |
Change since IPO | -99.17% |
Recent News & Updates
Recent updates
Shareholder Returns
ZOON.F | US Chemicals | US Market | |
---|---|---|---|
7D | 0% | 3.2% | 2.2% |
1Y | -60.0% | 13.6% | 32.6% |
Return vs Industry: ZOON.F underperformed the US Chemicals industry which returned 13.6% over the past year.
Return vs Market: ZOON.F underperformed the US Market which returned 32.6% over the past year.
Price Volatility
ZOON.F volatility | |
---|---|
ZOON.F Average Weekly Movement | n/a |
Chemicals Industry Average Movement | 5.4% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 15.8% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: ZOON.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine ZOON.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2007 | n/a | n/a | zoono.com |
Zoono Group Limited, together with its subsidiaries, engages in the research, development, and sale of a range of antimicrobial products in New Zealand, Australasia, Asia, the United States, India, the United Kingdom, and Europe. Its products include hand and surface sanitisers, textile applicator, and mould remediation products. The company serves facilities management, transportation, education, hospitality, and healthcare sectors.
Zoono Group Limited Fundamentals Summary
ZOON.F fundamental statistics | |
---|---|
Market cap | US$5.51m |
Earnings (TTM) | -US$5.30m |
Revenue (TTM) | US$611.39k |
9.0x
P/S Ratio-1.0x
P/E RatioIs ZOON.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ZOON.F income statement (TTM) | |
---|---|
Revenue | NZ$1.05m |
Cost of Revenue | NZ$5.83m |
Gross Profit | -NZ$4.78m |
Other Expenses | NZ$4.31m |
Earnings | -NZ$9.09m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.026 |
Gross Margin | -455.45% |
Net Profit Margin | -866.12% |
Debt/Equity Ratio | 0% |
How did ZOON.F perform over the long term?
See historical performance and comparison